A. Poljo, J. Reichl, Lars Kollmann, P. Kalinowski, Aleksandra Frankowska, M. Grąt, E. Felinska, U. Heger, S. Kopf, D. Noeva, C. Tuffs, M. Hepprich, Eleonora Seelig, R. Peterli, Marko Kraljević, J. Klasen, Beat P. Müller, R. Schneider, A. Billeter
2026.3.8DIABETES OBESITY & METABOLISM
tlooto Summary
This study examined whether these subphenotypes can predict outcomes in patients undergoing metabolic and bariatric surgery (MBS) and found that they can.
Abstract
Type 2 diabetes (T2D) is characterized by its clinical heterogeneity. Newly described T2D subphenotypes, each with distinct metabolic and co‐morbidity risk profiles, may enable a more personalized care. This study examined whether these subphenotypes can predict outcomes in patients undergoing metabolic and bariatric surgery (MBS).
Citation format
POLJO, A., et al. Type 2 diabetes subphenotypes are associated with differential outcomes after metabolic and bariatric surgery: An international multicentre retrospective cohort study. DIABETES OBESITY & METABOLISM, 2026, 28(5): 3681–3691.